ELAN in the 13F filings
Elanco Animal Health Inc · CUSIP 28414H103
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 11 Feb 2026
- Managers listing it
- 28
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 9 listed it in both
- Shares listed
- 159,640,954
- combined, among listed positions
- Reported value
- $3.6bn
- combined, at the quarter end
Among the 92 comparable managers: 17 buyers (opened or added shares) and 15 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -18,869,966.
Managers listing ELAN in Q4 2025
28 of 28 holders
Largest increases and reductions, by shares
Increases
- Invesco Ltdexisting position · 4,789,037 shares now+3,690,735
- Millennium Management LLCexisting position · 8,122,607 shares now+2,509,776
- T. Rowe Price Associates Incexisting position · 2,796,753 shares now+2,378,455
- ExodusPoint Capital Management LPexisting position · 763,331 shares now+491,617
- Steadfast Capital Management LPnew position · 473,200 shares now+473,200
Reductions
- Fidelity (FMR LLC)existing position · 52,196,321 shares now-13,161,059
- Dodge & Coxexisting position · 79,084,305 shares now-3,675,532
- Woodline Partners LPexisting position · 462,390 shares now-3,207,113
- Holocene Advisors LPexisting position · 329,191 shares now-1,763,863
- Citadel Advisors LLCexisting position · 3,698,126 shares now-1,145,254
New positions and exits
New (7)
Exited (6)
- Freestone Grove Partners LPwas $77m
- Point72 Asset Management LPwas $25m
- Marshall Wace LLPwas $7.4m
- Two Sigma Advisers LPwas $886k
- Winton Group Ltdwas $838k
- Walleye Capital LLCwas $422k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2018 | 13 | $388m | n.a. | n.a. |
| Q4 2018 | 7 | $383m | n.a. | n.a. |
| Q1 2019 | 14 | $3.5bn | n.a. | n.a. |
| Q2 2019 | 10 | $3.7bn | n.a. | n.a. |
| Q3 2019 | 13 | $2.9bn | n.a. | n.a. |
| Q4 2019 | 13 | $3.3bn | n.a. | n.a. |
| Q1 2020 | 13 | $2.9bn | n.a. | n.a. |
| Q2 2020 | 12 | $2.4bn | n.a. | n.a. |
| Q3 2020 | 6 | $2.9bn | n.a. | n.a. |
| Q4 2020 | 16 | $4.1bn | n.a. | n.a. |
| Q1 2021 | 12 | $4.0bn | n.a. | n.a. |
| Q2 2021 | 14 | $4.6bn | n.a. | n.a. |
| Q3 2021 | 10 | $4.0bn | n.a. | n.a. |
| Q4 2021 | 13 | $3.8bn | n.a. | n.a. |
| Q1 2022 | 11 | $3.1bn | n.a. | n.a. |
| Q2 2022 | 11 | $2.4bn | n.a. | n.a. |
| Q3 2022 | 15 | $1.9bn | n.a. | n.a. |
| Q4 2022 | 15 | $1.7bn | n.a. | n.a. |
| Q1 2023 | 12 | $1.2bn | n.a. | n.a. |
| Q2 2023 | 13 | $1.6bn | n.a. | n.a. |
| Q3 2023 | 12 | $1.7bn | n.a. | n.a. |
| Q4 2023 | 9 | $1.9bn | 2 | 9 |
| Q1 2024 | 10 | $2.3bn | 7 | 3 |
| Q2 2024 | 9 | $2.1bn | 6 | 4 |
| Q3 2024 | 7 | $1.5bn | 4 | 3 |
| Q4 2024 | 5 | $1.5bn | 2 | 2 |
| Q1 2025 | 6 | $1.5bn | 4 | 1 |
| Q2 2025 | 9 | $2.5bn | 8 | 2 |
| Q3 2025 | 12 | $3.4bn | 7 | 5 |
| Q4 2025 | 9 | $3.3bn | 17 | 15 |
| Q1 2026 | 5 | $3.0bn | 15 | 16 |
| Q2 2026 | 10 | $3.6bn | 15 | 15 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
ELAN and LLY →ELAN and JNJ →ELAN and VRTX →Choose a stock to compare with ELAN →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own ELAN, latest filings →Back to the 13F Explorer →